Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MOGAD”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableLooking for participantsNCT07202494
What this trial is testing

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)+7 more
Assistance Publique Hopitaux De Marseille 700
Testing effectiveness (Phase 2)Looking for participantsNCT06453694
What this trial is testing

Efgartigimod for the Treatment of Acute Optic Neuritis

Who this might be right for
Optic Neuritis
Anastasia Vishnevetsky, MD, MPH 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06452537
What this trial is testing

Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Tianjin Medical University General Hospital 102
Early research (Phase 1)Looking for participantsNCT06869278
What this trial is testing

LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 37
Not applicableLooking for participantsNCT04106830
What this trial is testing

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

Who this might be right for
NMO Spectrum DisorderMRIMultiple Sclerosis+1 more
Beijing Tiantan Hospital 1,000
Large-scale testing (Phase 3)Looking for participantsNCT05349006
What this trial is testing

Azathioprine in MOGAD

Who this might be right for
Central Nervous System InflammationMOG-IgG Associated Disease
Hospices Civils de Lyon 126
Not applicableLooking for participantsNCT05017142
What this trial is testing

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Who this might be right for
Optic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more
University of Bern 500
Large-scale testing (Phase 3)Looking for participantsNCT05063162
What this trial is testing

Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
UCB Biopharma SRL 104
Not applicableLooking for participantsNCT06865274
What this trial is testing

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Large-scale testing (Phase 3)Looking for participantsNCT05271409
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Hoffmann-La Roche 152
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36